Loading...
PanPath B.V., founded in 2002, is a privately owned enterprise based in Budel, The Netherlands. Established by scientists with expertise in pathology and molecular biology, PanPath combines deep scientific knowledge with extensive experience in commercial sectors specializing in antibodies, detection systems, and molecular biology. The company's journey began with the launch of the REMBRANDT® product group and has since been characterized by the development of a wide range of innovative, high-quality products, a global distributor network, and a reputation for reliability.
PanPath’s commitment to innovation is exemplified by continuous advancements in the REMBRANDT® product line and the creation of new tools for detecting cancer-related genetic markers. Designed for ease of use, these products meet rigorous production standards, including stringent quality control measures to ensure consistent, reproducible results with minimal lot-to-lot variation.
PanPath works closely with a network of skilled and knowledgeable distributors who receive regular training on the technology and applications of its products, ensuring excellent customer support and expertise.
PanPath B.V. develops, produces, and distributes diagnostic solutions for the pathology field. By working closely with scientists worldwide, the company addresses the practical needs of professionals in clinical practice.
PanPath aims to be a global leader in making diagnostic assays for pathology, focusing on creating faster, more reliable tools to improve patient care.
Infectious disease detection kits are vital tools for identifying pathogens quickly and accurately, enabling timely treatment and preventing further transmission. These kits leverage advanced technologies such as PCR, immunoassays, and next-generation sequencing to deliver high sensitivity, specificity, and rapid results.
Designed for ease of use and reliability, they support applications in diagnostic testing, epidemiological surveillance, antimicrobial resistance detection, and screening programs. By providing consistent and actionable insights, these products play a crucial role in improving patient outcomes and combating global health challenges.
